Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5-15 years in Australia

被引：2
|
作者：
Wood, Nicholas [1 ,2 ,6 ]
Lopez, Laura K. [1 ]
Glover, Catherine [1 ]
Leeb, Alan [3 ,4 ]
Cashman, Patrick [5 ]
Deng, Lucy [1 ,2 ]
Macartney, Kristine [1 ,2 ]
机构：
[1] Natl Ctr Immunisat Res & Surveillance, Westmead, NSW, Australia
[2] Univ Sydney, Childrens Hosp, Westmead Clin Sch, Westmead, NSW, Australia
[3] SmartVax, Ballajura, WA, Australia
[4] Illawarra Med Ctr, Ballajura, WA, Australia
[5] Hunter New England Populat Hlth, Newcastle, NSW, Australia
[6] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance, Westmead, NSW, Australia
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2023年 / 31卷
关键词：
D O I：
10.1016/j.lanwpc.2023.100684
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] COVID-19 Vaccines: Safe and Effective in Children Aged 5 to 11 Years
    Oliver, Sara E.
    Wallace, Megan
    Link-Gelles, Ruth
    PEDIATRICS, 2022, 150 (02)
  • [2] PEFR IN DUNEDIN CHILDREN AGED 5-15 YEARS
    STGEORGE, IM
    REID, JJ
    GRIMMOND, BB
    MORTON, R
    NEW ZEALAND MEDICAL JOURNAL, 1982, 95 (714) : 597 - 597
  • [3] THE BLOOD PRESSURES OF DUNEDIN CHILDREN AGED 5-15 YEARS
    STGEORGE, IM
    REID, JJ
    GRIMMOND, BB
    MORTON, RM
    NEW ZEALAND MEDICAL JOURNAL, 1981, 93 (679) : 145 - 148
  • [4] Safety Monitoring of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years by Using EudraVigilance Pharmacovigilance Database: The CoVaxChild Study
    Zinzi, Alessia
    Gaio, Mario
    Liguori, Valerio
    Ruggiero, Rosanna
    Tesorone, Marina
    Rossi, Francesco
    Rafaniello, Concetta
    Capuano, Annalisa
    VACCINES, 2023, 11 (02)
  • [5] Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years A Systematic Review and Meta-analysis
    Watanabe, Atsuyuki
    Kani, Ryoma
    Iwagami, Masao
    Takagi, Hisato
    Yasuhara, Jun
    Kuno, Toshiki
    JAMA PEDIATRICS, 2023, 177 (04) : 384 - 394
  • [6] mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation
    Fenton, Caroline
    Lee, Arnold
    DRUGS & THERAPY PERSPECTIVES, 2022, 38 (12) : 532 - 540
  • [7] mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation
    Caroline Fenton
    Arnold Lee
    Drugs & Therapy Perspectives, 2022, 38 : 532 - 540
  • [8] Adverse reactions and safety profile of the mRNA COVID-19 vaccines among Asian military personnel
    Tan, Joshua T. C.
    Tan, Clive
    Teoh, Jeremy
    Wahab, M. T.
    Tan, Guan Zhong
    Chin, Reon Yew Zhou
    Lee, Anne
    Mutalib, Adeliza
    Lim, Poh Lian
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2021, 50 (11)
  • [9] Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
    Trougakos, Ioannis P.
    Terpos, Evangelos
    Alexopoulos, Harry
    Politou, Marianna
    Paraskevis, Dimitrios
    Scorilas, Andreas
    Kastritis, Efstathios
    Andreakos, Evangelos
    Dimopoulos, Meletios A.
    TRENDS IN MOLECULAR MEDICINE, 2022, 28 (07) : 542 - 554
  • [10] Child mortality of children aged 5-15 years in the UK and Sweden: a comparison
    Tambe, Parag
    Sammons, Helen M.
    Choonara, Imti
    ARCHIVES OF DISEASE IN CHILDHOOD, 2016, 101 (04) : 409 - +
12345